Display Options:
Total: 50
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Amyotrophic Lateral Sclerosis; Depressive Disorder; Depressive Disorder, Major; Neuralgia, Postherpetic; Epilepsy; Seizures
KCNQ (Kv7) potassium channel opener
Small molecule
Approved
DERMATOLOGY; NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Kidney Diseases; Alcoholism; Diabetic Neuropathies; Migraine Disorders; Neuralgia, Postherpetic; Restless Legs Syndrome
Voltage-gated calcium channel modulator
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER; PEDIATRICS
ORAL
Alcoholism; Bipolar Disorder; Depressive Disorder, Major; Torticollis; Amyotrophic Lateral Sclerosis; Diabetic Neuropathies; Essential Tremor; Migraine Disorders; Neuralgia; Small Fiber Neuropathy; Epilepsy, Tonic-Clonic; Lennox Gastaut Syndrome; Parkinson Disease; Epilepsies, Partial; Epilepsy; Seizures
Glutamate receptor ionotropic AMPA antagonist
Protein
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM
INJECTION
Renal Insufficiency; Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis; Neoplasms
Interferon alpha/beta receptor agonist
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Orthostatic Intolerance; Attention Deficit Disorder with Hyperactivity; Fibromyalgia; Hypotension; Parkinson Disease; Cardiovascular Diseases; Hypotension, Orthostatic; Multiple System Atrophy
Adrenergic receptor agonist
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Sleep Apnea Syndromes; Tobacco Use Disorder; Alcoholism; Alzheimer Disease; Autistic Disorder; Opioid-Related Disorders; Restless Legs Syndrome; Sleep Wake Disorders; Smoking Cessation; Delirium; Sleep Initiation and Maintenance Disorders
Orexin receptor antagonist
Combination
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER; PHARMACOLOGY
BUCCAL; SUBLINGUAL
Unknown
Unknown
Combination
Approved
CANCER; NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Unknown
Unknown
Combination
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Unknown
Unknown
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
INTRAVENOUS; ORAL
Amyotrophic Lateral Sclerosis; Kidney Diseases; Alcoholism; Brain Neoplasms; Fibromyalgia; Neuralgia; Neuralgia, Postherpetic; Osteoarthritis; Paraganglioma; Anxiety; Dementia; Depressive Disorder; Diabetic Neuropathies; Erythromelalgia; Migraine Disorders; Schizophrenia; Sciatica; Status Epilepticus; Epilepsies, Partial; Epilepsy; Seizures
Sodium channel alpha subunit blocker
Combination
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Unknown
Unknown
Unknown
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM
UNKNOWN
Unknown
Unknown
Combination
Approved
MUSCULOSKELETAL; NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Unknown
Unknown
Combination
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Unknown
Unknown
Combination
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM
ORAL
Unknown
Unknown